Cizzle Biotechnology Holdings plc announces key collaborations and advancements in the development of a proprietary test for the CIZ1B biomarker for early-stage lung cancer detection...
Learn about Cizzle Biotechnology Holdings plc and their innovative blood test for early lung cancer detection in their recently published Annual Report...
Cizzle Biotechnology plc's Executive Chairman discusses new Licensing and Partnership MoU for North America, focusing on revenue streams and market expansion...
Learn how Cizzle Biotechnology plc (LON:CIZ) is expanding into the US and Canada with a strategic licensing agreement. Dr. Alan Syms explains the financial benefits and market strategies...
Cizzle Biotechnology Holdings plc signs exclusive licensing agreement to develop lung cancer diagnostic test in USA and Canada. Exciting partnership ahead!..
Cizzle Biotechnology Holdings PLC (LON:CIZ) has announced a conditional placing to raise £0.62 million for its commercial test development. Learn more here...
Cizzle Biotechnology Holdings plc announces key collaborations and advancements in the development of a proprietary test for the CIZ1B biomarker for early-stage lung cancer detection...
Learn about Cizzle Biotechnology Holdings plc and their innovative blood test for early lung cancer detection in their recently published Annual Report...
Cizzle Biotechnology plc's Executive Chairman discusses new Licensing and Partnership MoU for North America, focusing on revenue streams and market expansion...
Learn how Cizzle Biotechnology plc (LON:CIZ) is expanding into the US and Canada with a strategic licensing agreement. Dr. Alan Syms explains the financial benefits and market strategies...
Cizzle Biotechnology Holdings plc signs exclusive licensing agreement to develop lung cancer diagnostic test in USA and Canada. Exciting partnership ahead!..
Cizzle Biotechnology Holdings PLC (LON:CIZ) has announced a conditional placing to raise £0.62 million for its commercial test development. Learn more here...
